Baird Maintains Neutral on Dentsply Sirona, Lowers Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Jeffrey Johnson maintains a Neutral rating on Dentsply Sirona (NASDAQ:XRAY) but lowers the price target from $33 to $31.
July 22, 2024 | 10:58 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Baird analyst Jeffrey Johnson maintains a Neutral rating on Dentsply Sirona but lowers the price target from $33 to $31.
The lowered price target from $33 to $31 suggests a less optimistic outlook for Dentsply Sirona, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100